List of Tables
Table 1. Global Preventable Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Preventable Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Preventable Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Preventable Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Preventable Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Preventable Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Preventable Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Preventable Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Preventable Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Preventable Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Preventable Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Preventable Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Preventable Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Preventable Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Preventable Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Preventable Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Preventable Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Preventable Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Preventable Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Preventable Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Preventable Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Preventable Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Preventable Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Preventable Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Preventable Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Preventable Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Preventable Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Preventable Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Preventable Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Preventable Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Preventable Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Preventable Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Preventable Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Preventable Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Preventable Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Preventable Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Preventable Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Preventable Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Preventable Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Preventable Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Preventable Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Preventable Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Preventable Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Preventable Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Preventable Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Preventable Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Preventable Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Preventable Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Preventable Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Preventable Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Preventable Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Preventable Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Preventable Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Preventable Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Preventable Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Preventable Vaccines Price (USD/Unit) by Type (2020-2025)
Table 59. Global Preventable Vaccines Price (USD/Unit) by Type (2026-2031)
Table 60. Global Preventable Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Preventable Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Preventable Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Preventable Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Preventable Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Preventable Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Preventable Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Preventable Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Preventable Vaccines Price (USD/Unit) by Application (2020-2025)
Table 69. Global Preventable Vaccines Price (USD/Unit) by Application (2026-2031)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Preventable Vaccines Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Merck Preventable Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Preventable Vaccines Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Preventable Vaccines Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Preventable Vaccines Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Takeda Pharmaceutical Company Information
Table 96. Takeda Pharmaceutical Description and Business Overview
Table 97. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Takeda Pharmaceutical Preventable Vaccines Product
Table 99. Takeda Pharmaceutical Recent Developments/Updates
Table 100. Abbott Company Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Preventable Vaccines Product
Table 104. Abbott Recent Developments/Updates
Table 105. Roche Company Information
Table 106. Roche Description and Business Overview
Table 107. Roche Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Roche Preventable Vaccines Product
Table 109. Roche Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. AstraZeneca Preventable Vaccines Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Mitsubishi Tanabe Pharma Company Information
Table 116. Mitsubishi Tanabe Pharma Description and Business Overview
Table 117. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Mitsubishi Tanabe Pharma Preventable Vaccines Product
Table 119. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 120. Lupin Company Information
Table 121. Lupin Description and Business Overview
Table 122. Lupin Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Lupin Preventable Vaccines Product
Table 124. Lupin Recent Developments/Updates
Table 125. Serum Institute of India Company Information
Table 126. Serum Institute of India Description and Business Overview
Table 127. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Serum Institute of India Preventable Vaccines Product
Table 129. Serum Institute of India Recent Developments/Updates
Table 130. LG Life Sciences Company Information
Table 131. LG Life Sciences Description and Business Overview
Table 132. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. LG Life Sciences Preventable Vaccines Product
Table 134. LG Life Sciences Recent Developments/Updates
Table 135. S K Chemicals Company Information
Table 136. S K Chemicals Description and Business Overview
Table 137. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. S K Chemicals Preventable Vaccines Product
Table 139. S K Chemicals Recent Developments/Updates
Table 140. Shenzhen Kangtai Biological Products Company Information
Table 141. Shenzhen Kangtai Biological Products Description and Business Overview
Table 142. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Shenzhen Kangtai Biological Products Preventable Vaccines Product
Table 144. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 145. Sinovac Biotech Company Information
Table 146. Sinovac Biotech Description and Business Overview
Table 147. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Sinovac Biotech Preventable Vaccines Product
Table 149. Sinovac Biotech Recent Developments/Updates
Table 150. Janssen Pharmaceuticals Company Information
Table 151. Janssen Pharmaceuticals Description and Business Overview
Table 152. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Janssen Pharmaceuticals Preventable Vaccines Product
Table 154. Janssen Pharmaceuticals Recent Developments/Updates
Table 155. Crucell Company Information
Table 156. Crucell Description and Business Overview
Table 157. Crucell Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Crucell Preventable Vaccines Product
Table 159. Crucell Recent Developments/Updates
Table 160. Bavarian Nordic Company Information
Table 161. Bavarian Nordic Description and Business Overview
Table 162. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Bavarian Nordic Preventable Vaccines Product
Table 164. Bavarian Nordic Recent Developments/Updates
Table 165. Baxter Company Information
Table 166. Baxter Description and Business Overview
Table 167. Baxter Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Baxter Preventable Vaccines Product
Table 169. Baxter Recent Developments/Updates
Table 170. Bharat Biotech Company Information
Table 171. Bharat Biotech Description and Business Overview
Table 172. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Bharat Biotech Preventable Vaccines Product
Table 174. Bharat Biotech Recent Developments/Updates
Table 175. Dynavax Company Information
Table 176. Dynavax Description and Business Overview
Table 177. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Dynavax Preventable Vaccines Product
Table 179. Dynavax Recent Developments/Updates
Table 180. Bausch Health Company Information
Table 181. Bausch Health Description and Business Overview
Table 182. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Bausch Health Preventable Vaccines Product
Table 184. Bausch Health Recent Developments/Updates
Table 185. Protein Sciences Company Information
Table 186. Protein Sciences Description and Business Overview
Table 187. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Protein Sciences Preventable Vaccines Product
Table 189. Protein Sciences Recent Developments/Updates
Table 190. Panacea Biotec Company Information
Table 191. Panacea Biotec Description and Business Overview
Table 192. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Panacea Biotec Preventable Vaccines Product
Table 194. Panacea Biotec Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Preventable Vaccines Distributors List
Table 198. Preventable Vaccines Customers List
Table 199. Preventable Vaccines Market Trends
Table 200. Preventable Vaccines Market Drivers
Table 201. Preventable Vaccines Market Challenges
Table 202. Preventable Vaccines Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Preventable Vaccines
Figure 2. Global Preventable Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Preventable Vaccines Market Share by Type: 2024 & 2031
Figure 4. Adult Preventable Vaccines Product Picture
Figure 5. Pediatric Preventable Vaccines Product Picture
Figure 6. Global Preventable Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Preventable Vaccines Market Share by Application: 2024 & 2031
Figure 8. Bacterial Diseases
Figure 9. Virus Diseases
Figure 10. Global Preventable Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Preventable Vaccines Market Size (2020-2031) & (US$ Million)
Figure 12. Global Preventable Vaccines Sales (2020-2031) & (K Units)
Figure 13. Global Preventable Vaccines Average Price (USD/Unit) & (2020-2031)
Figure 14. Preventable Vaccines Report Years Considered
Figure 15. Preventable Vaccines Sales Share by Manufacturers in 2024
Figure 16. Global Preventable Vaccines Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Preventable Vaccines Players: Market Share by Revenue in Preventable Vaccines in 2024
Figure 18. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Preventable Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Preventable Vaccines Sales Market Share by Country (2020-2031)
Figure 21. North America Preventable Vaccines Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Preventable Vaccines Sales Market Share by Country (2020-2031)
Figure 25. Europe Preventable Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. Germany Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Preventable Vaccines Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Preventable Vaccines Revenue Market Share by Region (2020-2031)
Figure 33. China Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Preventable Vaccines Sales Market Share by Country (2020-2031)
Figure 43. Latin America Preventable Vaccines Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Preventable Vaccines Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Preventable Vaccines Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Preventable Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Preventable Vaccines by Type (2020-2031)
Figure 54. Global Revenue Market Share of Preventable Vaccines by Type (2020-2031)
Figure 55. Global Preventable Vaccines Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Preventable Vaccines by Application (2020-2031)
Figure 57. Global Revenue Market Share of Preventable Vaccines by Application (2020-2031)
Figure 58. Global Preventable Vaccines Price (USD/Unit) by Application (2020-2031)
Figure 59. Preventable Vaccines Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
